Movement Alert｜Charles River Laboratories Intraday Rise 5.06% in Regular Trading, Analyst Price-Target Increases Boost Sentiment

Market Focus10-20

On October 20, Charles River Laboratories recorded an Intraday Rise of 5.06% in Regular Trading, trading at $314.95, with turnover of $94.86 million.

The clearest catalyst was a fresh analyst price-target increase: JPMorgan raised its target to $345 from $310, while Morgan Stanley had earlier lifted its target to $340 from $300, reinforcing positive sentiment toward the shares.

Supporting the more constructive view, the company previously reaffirmed fiscal adjusted EPS guidance at the upper end of $11.15 to $11.45 and outlined low-double-digit EPS compound growth through 2030, while recent updates on digital lab execution and development-testing partnerships added to the medium-term growth narrative.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment